Case report · 24 Aug 2015
Conference abstractPublished 13 Jun 2016
Thyroid carcinoma in multi-nodular goiter
Mother Teresa University Hospital Center, Albania
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: The incidence of malignancy in toxic multi-nodular goiter (TMNG), non-toxic multi-nodular goiter (nTMNG) and GravesâÂ?Â? disease (GD), has historically been thought to be low (5% to 10%). Many authors have claimed that hyperthyroidism protects against thyroid cancer and also believed that multi-nodularity does seem to be a certain indicative factor of benign disease. Recent studies have suggested a much higher rate of malignancy within toxic and non-toxic MNG (10% to 22%). We designed this study to determine the prevalence of incidental cancer in patients undergoing thyroidectomy for presumed benign disease. Methods: The aim of this study is to evaluate the incidence of thyroid carcinoma in multi-nodular goiters (MNG) and the pathological pattern of these cancer nodules. It is a retrospective review of cases operated from January 2010 to December 2012, at "Mother Teresa" University Hospital Center, Tirana, Albania. Patients undergoing thyroidectomy for MNG, TMNG, or GD performed by members of the Department of General Surgery, were included in the study. Histology reports of patients treated surgically with a preoperative diagnosis of toxic and non-toxic multi-nodular goiter were reviewed to identify the thyroid cancer incidence. Patients having a history of neck irradiation or radioactive iodine therapy were excluded from the study. Patients with preoperative FNA results that were malignant or indeterminate were excluded. The cancer rate was calculated and univariate and multivariate analyses were performed to identify predictors of malignancy. Results: We operated on 545 patients for MNG, out of whom 98 patients presented to us in a toxic state (15 GD and 83 toxic MNG) and the remaining 447 in a non-toxic state. Of the patients operated for MNG 7.7% were found to have associated thyroid cancer. The incidence of thyroid cancer in toxic MNG patients was 13.25% whereas in non-toxic MNG patients it was 6.9%. The malignant nodules detected were papillary cancers of the thyroid in 76% of cases, follicular cancers in 9.5% of cases, oncocytic type in 7.3% of cases, insular carcinoma in 2.5% and anaplastic cancer in 4.7%. The median age at surgery was 44.6 years, 8.6% of the cohort had thyroiditis and 68% underwent preoperative FNA biopsy. Male patients represented 15.04% of the entire cohort but 23.8% of cancers were in men. The risk of cancer was higher in nodular goiter than diffuse goiter. The highest rate of cancer was found in TMNG (13.25%) and the lowest was in GD (0%). Conclusion: There was a higher than expected rate of incidenÃ?¬tal cancer in TMNG (13.25%), n-TMNG (6.9%) and GD (0%). Thyroid cancers can coexist in toxic MNG despite the suppression of thyroid stimulating hormone (TSH). Given this high rate of inciÃ?¬dental cancer, a total thyroidectomy should be the preferred approach for patients undergoing surgery for bilateral nodular disease.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Short communication · 25 Nov 2021
Surgical Multi-Nodular Goiter
Case report · 2016
Multi-nodular Goiter
Case report · 2016
Multi-nodular Goiter
Case report · 2016
Incidental Growth Hormone Producing Pituitary Adenoma in a Case of Recurrent Nodular Goiter and Thyroid Carcinoma
More from this journal
The newest in Cancer Science & Therapy.
Commentary · 21 Feb 2026
Functional Immune Biomarker Identification in Patients with Breast Cancer
Perspective · 21 Feb 2026
Finding Potential Passerini Adducts for Anticancer Drug Development
Perspective · 21 Feb 2026
Head and Neck Cutaneous Squamous Cell Carcinoma with Perineural Invasion
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCancer Science & Therapy
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Rovena Bode”
- BylineArticles whose byline prints “Etmond Celiku”
- BylineArticles whose byline prints “Medi Alimehmeti”

